Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16
ADAPTHEALTH CORP
ADAPTHEALTH CORP AHCO | 0.00 |
Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:
AHCO) with a Buy and raises the price target from $14 to $16.
